Qitan Tech makes nanopore gene sequencers, reagents and software for pathogen, cancer and genetic disease research.
Based in Chengdu, China, and established in 2016, Chengdu Qitan Technology Co., Ltd., trading as Qitan Tech, works on gene sequencing and gene diagnostics through nanotechnology. Its founder is Dr. Bai Jinwei, a postdoctoral fellow in the IBM Watson Laboratory. The company released the QNome-9604 nanopore gene sequencer in 2020 and the QPursue medium flux nanopore platform in August 2023. In December 2025, it raised venture funding from Zhongguancun Venture Capital and Beishang Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in